TransCode Therapeutics wins Australia notice acceptance and Japan patent
TransCode Therapeutics received an Australian Notice of Acceptance and a granted Japanese patent covering RNA-based cancer therapies and delivery platforms, reinforcing its IP for immuno-oncology.
TransCode Therapeutics received an Australian Notice of Acceptance and a granted Japanese patent covering RNA-based cancer therapies and delivery platforms, strengthening its intellectual property position in immuno-oncology.